Healthpeak has raised its 2026 adjusted FFO and same-store NOI guidance after a quarter of strong senior housing growth, leasing activity and portfolio expansion. The uplift comes with a lower GAAP earnings outlook, reflecting depreciation from newly acquired senior housing assets.
- Adjusted FFO guidance increased to US$1.76-US$1.78 per share
- Janus Living revenue rose 78% and Adjusted EBITDAre climbed 101% year on year
- Approximately US$233 million of life science acquisitions announced or contracted
- Lab occupancy rose 270 basis points from year-end 2025
- Net debt to Adjusted EBITDAre stood at 4.7x
Healthpeak Properties, Inc. (NYSE:DOC) raised its 2026 adjusted FFO guidance after reporting a quarter powered by senior housing growth and continued leasing momentum, although its GAAP earnings outlook moved lower. The healthcare property owner now expects diluted FFO as Adjusted of US$1.76 to US$1.78 per share, up from US$1.73 to US$1.77, while diluted earnings guidance fell to US$0.39 to US$0.41 per share from US$0.48 to US$0.52. Healthpeak said the earnings reduction primarily reflects depreciation and amortisation from senior housing acquisitions made by majority-owned Janus Living.
Bottom Line?
The upgraded operating guidance is encouraging, but the next test is whether acquisition-led growth can translate into durable per-share earnings without pushing leverage materially higher.
Questions in the middle?
- Can Janus Living sustain its rapid growth as the enlarged senior housing portfolio is integrated?
- Will the contracted life science assets reach the projected 9% to 10% stabilised cash yield?
- How much further can Healthpeak expand while maintaining its 4.7x net debt to Adjusted EBITDAre ratio?